Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06178952
NA

Transcranial Pulse Stimulation (TPS) in Post-COVID-19

Sponsor: Medical University of Vienna

View on ClinicalTrials.gov

Summary

The objective of the present study is to demonstrate treatment efficacy of transcranial pulse stimulation for patients with Post-COVID-19 related neurological symptoms (fatigue, cognitive deficits, mood deterioration). Fatigue, as measured by the Fatigue Impact Scale (FIS), will represent the primary outcome variable. The verum treatment will be compared to a sham (placebo) condition.

Key Details

Gender

All

Age Range

20 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

102

Start Date

2024-01-08

Completion Date

2027-01

Last Updated

2025-12-23

Healthy Volunteers

No

Interventions

DEVICE

Transcranial pulse stimulation Verum

Participants are slated to undergo a total of five TPS sessions over a 10-day interval. Each stimulation session will endure approximately 30 minutes and will be administered once daily.

DEVICE

Transcranial pulse stimulation Sham

Placebo treatment will be performed using the same medical device, handpiece and treatment paradigm as in the verum treatment with one difference: the standoff device at the end of the handpiece. This device is designed to replicate the appearance, feel, and sound of the verum system, while omitting the transmission of any pulses.

Locations (1)

Medical University of Vienna

Vienna, Vienna, Austria